BeStock  
Markets › Compare › ESQ vs COAG

ESQ vs COAG

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ESQ · Esquire Financial$118.02 ▼ 1.58%
COAG · Hemab Therapeutics Holdings$30.59 ▼ 1.67%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6893118142167May 1, '26Jul 20, '26Oct 5, '26
  • ESQ +10.7%
  • COAG -10.0%

Head to head

MetricESQCOAG
Price$118.02$30.59
Change today▼ 1.58%▼ 1.67%
Market cap$1.43B$1.43B
Return, 3 months-1.9%-2.9%
Return, year to date+16.2%–
Return, 1 year+13.6%–
P/E (TTM)19.5-17.2
P/B4.63.1
P/E percentile vs own 5y––
Dividend yield0.64%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)4622
30-day volatility26.3%59.2%
Max drawdown, 1 year-15.9%-44.3%
Trend readLeaning bearishStrong downtrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • COAG is the largest of the group by market value.
  • COAG carries the lowest trailing P/E.
  • ESQ has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top